Treatment of Vulvo-vaginal Atrophy (VVA) Using Vaginal Dilator in Addition to Usual Treatment

Abroad (travel likely)Recruiting

Conditions

Vulvo Vaginal Atrophy · Genitourinary Syndrome of Menopause (GSM) · Vaginal Atrophy in Breast Cancer Patients · Vaginal Atrophy Patients With GSM · Treatment · Sexual Disfunction · Dyspareunia (Female)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Saint Pierre University Hospital Center, Brussels, Brussels Capital, Belgium
Contact: Study coordinator (Julie Piral, medical student) · julie.piral@ulb.be · +33673428392
Contact: Study coordinator (Aurélie Joris, Gynaecologist) · aurelie.joris@stpierre-bru.be · +32 2 535 3486
Contact: Principal Investigator (Julie Piral, medical student)

Study leads

Serge Rozenberg, Gynaecologist
Study Director
Saint Pierre University Hospital Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy

Vulvar Atrophy · Vaginal Atrophy

IsraelRecruiting

Hadera, Israel

Determining the Extent of the Genitourinary Syndrome of Menopause Burden in Breast Cancer Survivors

Genitourinary Syndrome of Menopause (GSM) · Breast Cancer · Vulvovaginal Atrophy

Abroad (travel likely)Recruiting

Hasselt, Belgium

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Vulvar Atrophy · Vulvovaginal Signs and Symptoms · Genitourinary Syndrome of Menopause

Abroad (travel likely)Recruiting

Madrid, Spain

Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal Women

Vulvo Vaginal Atrophy (VVA)

Abroad (travel likely)RecruitingPHASE2

Saint Paul, United States